Picture of Cann logo

CAN — Cann News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapTurnaround

Australia's Cann Group rises on drug marketing deal

** Shares of Cann Group Ltd  CAN.AX  rise as much as 4.2% to
A$0.25, their highest since Oct 25
    ** Medicinal cannabis maker signs non-binding term sheet for
Haleon Plc  HLN.L  to market its Satipharm CBD capsules within
Australia and New Zealand  urn:newsml:reuters.com:*:nASX2g2mwn
    ** CBD-Satipharm capsule is an over-the-counter potential
drug to treat sleep disturbances
    ** CAN stock posts its biggest intraday pct gain since Oct
28
    ** Nearly 693,100 shares change hands, vs the 30-day average
volume of about 404,700 shares
    ** Stock down 17.3% this year, as of last close
 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))

Recent news on Cann

See all news